Friday, April 16, 2021 12:15:24 PM
In the three calls that Ampio Pharmaceuticals has held since the first release of the Fox (local Fox in Colorado) video of the success injected Ampion had on patients in Colorado, they have talked about being bought out. Its their end goal, get approved and wait for the bidding to start. Small biotech companys are nothing more then an unfunded R&D minor league for the major pharma companys. The use them to keep their own cost in check by not having to look at every possible area to develop their own drugs. Big pharma picks and chooses where they will focus the billions on R&D they will spend in house. All the while watching every OTCQB or barely qualified American, NYSE or NASDAQ stock listed biotech to snatch up when the time is right.
Government is corrupt no doubt in my mind and they all, the people who run it, make money off of what ever they can. But the FDA is very careful in how they do it... mass loss of life or injury due to faulty results that are approved, thats something even the liberal news, run by blind to the fact morons, would pounce on. Example is they are running J&J over the coals for the blood clot problems their vaccine is having. Eeven though the FDA and Fouche are telling us daily J&J problems will all be ok very soon... and we should not panic.
Recent AMPE News
- Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation • PR Newswire (US) • 04/03/2024 06:33:00 PM
- Ampio Announces Voluntary Delisting and SEC Deregistration • PR Newswire (US) • 03/25/2024 09:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/05/2024 05:15:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 08:49:00 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 02/28/2024 08:48:05 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 02/28/2024 08:47:17 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/28/2024 08:46:20 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 02/28/2024 08:45:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 02:31:23 PM
- Ampio Provides Update on Results from Pre-IND Enabling Studies • PR Newswire (US) • 02/14/2024 10:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:31:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/25/2024 09:18:53 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/24/2024 10:16:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:20:20 PM
- Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions • PR Newswire (US) • 01/11/2024 09:15:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/21/2023 09:25:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:10:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 01:30:24 PM
- Ampio Pharmaceuticals to Present at the Emerging Growth Conference • PR Newswire (US) • 10/31/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 06:10:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 06:56:04 PM
- Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201 • PR Newswire (US) • 10/05/2023 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 08:15:24 PM
- Ampio Pharmaceuticals to Present at the Emerging Growth Conference • PR Newswire (US) • 09/26/2023 01:15:00 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM